Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 60 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
591 16.3 months Hepatocellular carcinoma 5 Biologic therapy
Chemotherapy
UCL Medical School United Kingdom 2/2013
Treatment Details: Patients: This phase 2 study involved untreated hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A consisted of 42 patients with a median age of
 
592 16.3 months Melanoma 4 Biologic therapy
University of Pittsburgh Cancer Institute United States 10/2011
Treatment Details: Patients: This phase 2 study involved 41 patients with metastatic melanoma of originating from the skin or eye who had not received prior chemotherapy. The median patient age was 57 years
 
593 16.3 months colorectal (untreated metastatic) 3 Biologic therapy
Chemotherapy
University of North Carolina United States 7/2006
Treatment Details: Patients: This trial involved a total of 305 patients with previously untreated metastatic colorectal cancer. Patients were divided into two groups Group A with 151 patients and Group B w
 
594 16.3 months Ovarian or primary peritoneal cancer 4 Biologic therapy
Fox Chase Cancer Center United States 7/2008
Treatment Details: Patients: This phase II study involved 60 women with ovarian cancer or primary peritoneal cancer. Most (46) had ovarian cancer. The median age was 63, ranging from 34 to 90 years. Tre
 
595 16.3 months Recurrent ovarian cancer 5 Biologic therapy
Indiana University School of Medicine United States 1/2011
Treatment Details: Patients: This study involved 71 women with recurring ovarian cancer or primary peritoneal carcinomatosis. The median patient age was 60 years. Treatment: Patients were treated with t
 
596 16.3 months Advanced renal cell carcinoma 3 Biologic therapy
McGill University Canada 8/2002
Treatment Details: Patients: This Phase II study involved 22 patients with advanced renal cell carcinoma; 11 men and 11 women. Eighteen had undergone prior nephrectomy. Patients were divided into two groups
 
597 16.3 months Metastatic renal cell carcinoma 4 Immunotherapy
Aarhus University Hospital Denmark 3/2002
Treatment Details: Patients: This Phase II study involved 46 patients with metastatic renal cell carcinoma, 34 men and 12 women. The median age was 57. Prior therapies included nephrectomy (27 patients), rad
 
598 16.3 months Locally advanced NSCLC 5 Chemotherapy
Radiation
University Hospital France 9/2005
Treatment Details: Patients: This Phase III study involved 201 patients with advanced non-small-cell lung cancer who were randomly assigned into two groups. Group B had 85 men and 15 women with a median age o
 
599 16.3 months Locally advanced NSCLC 5 Chemotherapy
Radiation
University of Pittsburgh Cancer Institute United States 9/2005
Treatment Details: Patients: This Phase II/III study involved 276 patients with advanced non-small-cell lung cancer who were randomly assigned into three groups. Group C had 92 patients (62 men, 30 women); tw
 
600 16.2 months metastatic breast cancer 4 Chemotherapy
Erasmus University Medical Center Netherlands 10/2005
Treatment Details: Patients: This Phase II/III study involved 216 women with metastatic breast cancer who were randomly assigned into two groups. Group B had 107 women (median age 54). Metastatic sites inclu
 
Page 60 of 187  | Previous Page  | Next Page